Back
The RealReal Vs. Blueprint Medicines Industry Stock Comparison
Buy
58
REAL
The RealReal
Last Price:
$8.59
Seasonality Move:
-2.93%
Sell
43
BPMC
Blueprint Medicines
Last Price:
$102.47
Seasonality Move:
5.27%
Buy
58
The RealReal (REAL)
is a Buy
Is The RealReal a Buy, Sell or Hold?
-
The current The RealReal [REAL] share price is $8.15. The Score for REAL is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
REAL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $103.36. The Score for BPMC is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
REAL Stock Price Chart
What is The RealReal's stock price today?
-
The The RealReal share price today is $8.15The current trend is moderately bearish and REAL is experiencing slight selling pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $103.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
REAL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.56 | Buy |
Relative Strength Index (14 RSI): | 45.83 | Sell |
Chaikin Money Flow: | -233323 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.03 - 10.33) | Sell |
Bollinger Bands (100): | (2.15 - 7.53) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 65.19 | Buy |
Chaikin Money Flow: | 1951173 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (88.25 - 95.81) | Buy |
Bollinger Bands (100): | (87.04 - 95.76) | Buy |
REAL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.34 | Sell |
20-day SMA: | 9.48 | Sell |
50-day SMA: | 6.77 | Buy |
200-day SMA: | 4.19 | Buy |
8-day EMA: | 9.09 | Sell |
20-day EMA: | 8.97 | Sell |
50-day EMA: | 7.36 | Buy |
200-day EMA: | 4.61 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 91.01 | Buy |
20-day SMA: | 91.26 | Buy |
50-day SMA: | 93.56 | Buy |
200-day SMA: | 96.81 | Buy |
8-day EMA: | 92.7 | Buy |
20-day EMA: | 91.91 | Buy |
50-day EMA: | 92.32 | Buy |
200-day EMA: | 91.6 | Buy |
The RealReal Earnings Growth & REAL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.24 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.
The RealReal Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |